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Agrobacterium tumefaciens transfers oncogenic T-DNA and effector proteins to plant cells via a type IV
secretion pathway. This transfer system, assembled from the products of the virB operon, is thought to consist
of a transenvelope mating channel and the T pilus. When screened for the presence of VirB and VirE proteins,
material sheared from the cell surface of octopine strain A348 was seen to possess detectable levels of VirB2
pilin, VirB5, and the VirB7 outer membrane lipoprotein. Material sheared from the cell surface of most virB
gene deletion mutants also possessed VirB7, but not VirB2 or VirB5. During purification of the T pilus from
wild-type cells, VirB2, VirB5, and VirB7 cofractionated through successive steps of gel filtration chromatog-
raphy and sucrose density gradient centrifugation. A complex containing VirB2 and VirB7 was precipitated
from a gel filtration fraction enriched for T pilus with both anti-VirB2 and anti-VirB7 antiserum. Both the
exocellular and cellular forms of VirB7 migrated as disulfide-cross-linked dimers and monomers when samples
were electrophoresed under nonreducing conditions. A mutant synthesizing VirB7 with a Ser substitution of
the lipid-modified Cys15 residue failed to elaborate the T pilus, whereas a mutant synthesizing VirB7 with a
Ser substitution for the disulfide-reactive Cys24 residue produced very low levels of T pilus. Together, these
findings establish that the VirB7 lipoprotein localizes exocellularly, it associates with the T pilus, and both
VirB7 lipid modification and disulfide cross-linking are important for T-pilus assembly. T-pilus-associated
VirB2 migrated in nonreducing gels as a monomer and a disulfide-cross-linked homodimer, whereas cellular
VirB2 migrated as a monomer. A strain synthesizing a VirB2 mutant with a Ser substitution for the reactive
Cys64 residue elaborated T pilus but exhibited an attenuated virulence phenotype. Dithiothreitol-treated T
pilus composed of native VirB2 pilin and untreated T pilus composed of the VirB2C64S mutant pilin distrib-
uted in sucrose gradients more predominantly in regions of lower sucrose density than untreated, native T pili.
These findings indicate that intermolecular cross-linking of pilin monomers is not required for T-pilus
production, but cross-linking does contribute to T-pilus stabilization.
Bacterial type IV secretion systems are of significant clinical
concern. The type IV systems are composed of the well-known
conjugation machines that are responsible for the rapid trans-
mission of antibiotic resistance genes throughout bacterial
populations under selective pressure (10, 27). Type IV systems
also are composed of a more recently described group of se-
cretion machines that mediate the delivery of effector mole-
cules to the cytosols of eukaryotic cells during infection (8, 23).
The list of medically important pathogens that utilize type IV
systems for interkingdom macromolecular translocation now
includes Helicobacter pylori, Bordetella pertussis, Legionella
pneumophila, and Brucella and Bartonella species. All type IV
systems share two common features: (i) these systems export
macromolecules to other cells, usually via cell-to-cell contact,
and (ii) these systems are ancestrally related to conjugation
machines. These features distinguish the type IV systems from
other bacterial secretion systems such as the ATP-binding cas-
sette superfamily (type I) (18), the terminal branch of the
general secretory pathway (type II) (31), the secretion systems
ancestrally related to flagella (type III) (25), the immunoglob-
ulin A autotransporters (type V) (31), and the recently de-
scribed Tat export pathway (34).
Agrobacterium tumefaciens uses a type IV secretion system to
export oncogenic T-DNA and proteins to susceptible plant
cells during infection. The products of the virB operon and of
the virD4 gene are required for type IV secretion. These pro-
teins are proposed subunits of a gated channel through which
substrates are translocated and of an extracellular pilus that
mediates productive contacts with target cells. A general pic-
ture is emerging about the assembly pathway and structure of
the T-DNA transfer system (8, 23). However, it is still not
known where and how T-pilus polymerization initiates at the
cell envelope or indeed whether the T pilus is physically joined
to the mating channel. One model suggests that T-pilus poly-
merization begins at the inner membrane and proceeds out-
ward through the periplasmic space and across the outer mem-
brane, presumably through a gated structure. This model is
reminiscent of the pathway by which Pseudomonas aeruginosa
and many other pathogens assemble the type IV family of pili
(which show no common ancestry with the pili elaborated by
type IV secretion systems, i.e., the A. tumefaciens T pilus) (26).
An alternative model suggests that the T-pilus subunits are
delivered across the periplasm by the action of a chaperone to
an outer membrane complex corresponding to the site of pilus
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assembly. This model is analogous to the chaperone-usher
system used in type 1 pilus biogenesis (32).
VirB2 is the structural subunit of the A. tumefaciens T pilus
(22). VirB2 undergoes two novel processing reactions, cleav-
age of an unusually long ;5-kDa signal sequence and cycliza-
tion via formation of a covalent bond between the N-terminal
Asp and C-terminal Glu residues (12, 22). Recent evidence
suggests that the VirB5 protein associates in small amounts
with the T pilus. VirB5 localizes predominantly in the
periplasm where it might participate in T-pilus assembly, al-
though genetic findings have been interpreted as evidence for
the association of VirB5 along the length or at the tip of the T
pilus (29).
In this study, we initiated work on the T-pilus assembly
pathway. The likely outer membrane components participating
in assembly include the small (4.5-kDa) outer membrane li-
poprotein VirB7, VirB3, and VirB9. In previous studies, it was
reported that VirB7 assembles as a disulfide-cross-linked ho-
modimer and a heterodimer with VirB9 (1, 2, 30). Further,
VirB7-VirB9 heterodimer formation was shown to have a sta-
bilizing effect on several VirB proteins, leading to the proposal
that the heterodimer functions as a nucleation center during
biogenesis of the transporter T pilus (3, 14). Here, we have
assayed for the association of VirB proteins with T pili purified
from the cell surface of octopine strain A348. We report that
the VirB7 monomer and homodimer, but not the VirB7-VirB9
heterodimer, are readily removed from the cell surface upon
shearing. Furthermore, the VirB7 monomer and homodimer
copurify with the T pilus. Mutational studies established the
importance of VirB7 lipid modification and disulfide cross-
linking for elaboration of the T pilus and identified a possible
stabilizing effect of intermolecular disulfide cross-linking
among VirB2 pilin subunits. Our findings support a model
whereby sorting of the VirB7 lipoprotein as homo- and het-
eromultimeric complexes to the outer face of the outer mem-
brane is a critical intermediate step in T-pilus biogenesis.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. A348 is A. tumefaciens
strain A136 containing pTiA6NC (15). The A348 derivatives, PC1001 to PC1011,
carry nonpolar null mutations of virB1 to virB11, respectively (4). In the A348
derivative PC1000, the entire 9.5-kb virB operon is deleted from pTiA6NC (13).
Plasmids pXZ16 and pXZ14 express virB7 derivatives with Ser codon substitu-
tions for the Cys15 and Cys24 codons, respectively (30). Plasmid pVS10, which
expresses virB2 with a Cys64-to-Ser substitution mutation, was constructed by
oligonucleotide-directed mutagenesis with uracil-containing pBB8 (4) template
and the mutagenic oligonucleotide 59-GGATAAACGTACTTATATTGTTAA
CC-39 according to the method of Kunkel et al. (20). The mutation was con-
firmed by sequencing across the virB fragment using an ABI 373A DNA se-
quencer (Perkin-Elmer). Plasmid pVS8, which expresses a glutathione
S-transferase (GST)–VirB2 fusion protein, was constructed by PCR amplifica-
tion of codons 48 to 121 of VirB2 with oligonucleotides 59-CGGGATCCCAA
TCTGCGGGTGGCGGCACC-39 and 59-GGAATTCTCAACTACCGCCAGT
GAGCGTTTG (BamHI and EcoRI sites are underlined). The amplified 200-bp
BamHI-EcoRI fragment was ligated to the GST expression vector, pGEX-2T
(Pharmacia).
Bacterial media and growth conditions have been previously described (13).
For induction of the vir genes, A. tumefaciens cells were grown in MG/L medium
to an optical density at 600 nm (OD600) of 0.5, harvested by centrifugation, and
inoculated at an initial OD600 of 0.2 into induction medium (IM) (AB mimimal
medium [pH 5.5] containing 1 mM phosphate supplemented with 200 mM ace-
tosyringone [AS]) (13). Cultures were incubated with shaking at 22°C for 18 h
and then harvested for protein analysis. In A. tumefaciens and Escherichia coli,
plasmids were maintained by the addition of carbenicillin (50 mg/ml), kanamycin
(50 mg/ml), or tetracycline (5 mg/ml) to the growth medium.
Protein analysis and immunoblotting. Proteins were resolved by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or a Tricine-SDS-
PAGE system as previously described (28). Vir proteins were visualized by
SDS-PAGE, protein transfer to nitrocellulose membranes, and immunoblot de-
velopment with goat anti-rabbit antibodies conjugated to alkaline phosphatase
and histochemical substrates. Alternatively, blots were developed with anti-rab-
bit antibodies conjugated to horseradish peroxidase and antibody-antigen inter-
actions were visualized by chemiluminescence (Amersham, Arlington Heights,
Ill.). Molecular size markers were from GIBCO-BRL (Grand Island, N.Y.).
Antibody specificities were previously documented for the VirB1, VirB4,
VirB5, VirB7 through VirB11, and VirE2 proteins (see reference 36). Anti-
VirB2 antiserum was raised by overproduction and purification of a GST-VirB2
fusion protein from E. coli BL21(DE3, pVS8). Briefly, a 100-ml culture was
grown to an OD600 of 0.3, IPTG (isopropyl-b-D-thiogalactopyranoside) (1 mM
final concentration) was added to induce gst-9virB2 expression, and cells were
incubated with shaking for 4 h at 37°C. GST-9VirB2 present in the soluble
fraction of cell lysates was purified by passage through a glutathione column and
elution according to the manufacturer’s instructions (Pharmacia). Purified GST-
9VirB2 was sent to Cocalico Biologicals, Inc. (Reamstown, Pa.), for injection into
New Zealand White rabbits.
Purification of T pili. T pili were isolated according to the protocol of Lai and
Kado (22). Briefly, A. tumefaciens strains were grown to an OD600 of 0.5 in MG/L
medium at 28°C. Cells were pelleted, diluted fivefold in IM, and incubated for 6 h
at 22°C. Two hundred microliters of AS-induced culture was spread on IM agar
plates, and the plates were incubated for 3 days at 18°C. Cells were then gently
scraped off the plates in 50 mM KPO4 buffer, pH 5.5, and pelleted by centrifu-
gation at 14,000 3 g for 15 min at room temperature. The supernatant was
removed and the cell pellet was resuspended in 50 mM phosphate buffer. This
suspension was passed through a 25-gauge needle 10 times to collect flagella, pili,
and surface proteins. The sheared bacterial cells were pelleted by centrifugation
at 14,000 3 g for 30 min at 4°C. The remaining supernatant was filtered through
a 0.22-mm-pore-size cellulose acetate membrane to remove unpelleted cells.
When necessary, culture supernatants and sheared materials were concentrated
with trichloroacetic acid or acetone as described previously (21).
T pili were purified by successive fractionation of exocellular material with gel
filtration and sucrose density gradient centrifugation. The exocellular material
suspended in 50 mM Tris (pH 8)–50 mM MgCl2 (buffer A) was applied at a total
protein concentration of 10 mg/ml to a gel filtration column (30 by 1.5 cm)
prepared with Toyopearl HW55 resin (TosoHaas, Montgomeryville, Pa.) accord-
ing to the manufacturer’s instructions. Material was fractionated with a Phar-
macia Gradi-frac chromatography system with a flow speed of 0.6 ml/min, and
fractions of 1.0 ml were collected. Fractions were analyzed for the presence of
Vir proteins, by SDS-PAGE and immunodevelopment of blots as described
above, or for the presence of total proteins, by silver staining of polyacrylamide
gels. Protein molecular size markers included apoferritin (443 kDa), alcohol
dehydrogenase (150 kDa), bovine serum albumin (66 kDa), carbonic anhydrase
(29 kDa), and cytochrome c (12 kDa). Size markers were electrophoresed both
together with and independently of the test sample. Gel filtration fractions
containing VirB2 pilin were layered on top of a 20 to 70% linear sucrose density
gradient (5 ml) prepared with buffer A and ultracentrifuged in an SW55 Beck-
man rotor at 80,000 3 g for 20 h at 4°C. Fractions of 0.5 ml were collected from
the bottoms of the centrifugation tube and analyzed for the presence of Vir
proteins by immunoblotting and for the presence of other proteins by silver
staining. Immunoprecipitation with anti-VirB antiserum was carried out as pre-
viously described (28).
Electron microscopy. Five microliters of purified T pili suspended in 50 mM
Tris-HCl (pH 8.0)–50 mM MgCl2 buffer was deposited on carbon-Formvar films
on 300-mesh, 3-mm2 copper grids. Samples were placed on grids for 30 s, excess
liquid was removed, and the grids were rinsed three times by successive additions
of triple-distilled H2O for 30 s. Samples were then stained with 2% uranyl acetate
for 45 s and rinsed again with H2O before air drying.
Virulence assays. Virulence assays were performed by inoculating wound sites
of Kalanchoe daigremontiana leaves with ;108 CFU of the various bacterial
strains. Controls for the tumorigenesis assays included coinoculating the same
leaf with wild-type A348 (virulent), avirulent DvirB mutants (4), and the various
test strains. Each experiment was repeated at least four times, and tumor for-
mation was monitored over a 3- to 4-month period.
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RESULTS
Cofractionation of VirB2 and VirB7 during T-pilus purifi-
cation. We isolated the T pilus from the octopine strain A348
according to a protocol developed by C. Kado and colleagues
(21). Briefly, cells were induced for vir gene expression on agar
plates, harvested, and sheared by successive passaging through
a narrow-gauge needle. Cells were then removed from the
exocellular fraction by low-speed centrifugation and filtration,
and the surface proteins and organelles were concentrated by
high-speed centrifugation. Silver staining of the concentrated
exocellular material showed the presence of numerous protein
species (data not shown), and immunoblot analysis showed the
presence of VirB2, VirB5, and the outer membrane lipopro-
tein VirB7 (Fig. 1). Blots shown in Fig. 1 were developed with
an alkaline phosphatase substrate. We were unable to detect
VirB proteins other than VirB2, VirB5, and VirB7 in concen-
trated exocellular fractions either by development of blots with
alkaline phosphatase or with chemiluminescence (data not
shown). We also were unable to detect a species corresponding
to VirB1p, a proteolytic fragment of VirB1 encoded by the
nopaline pTiC58 plasmid (24), in either the cellular or exocel-
lular fractions of A348, which carries the octopine plasmid
pTiA6NC. Finally, we did not detect the periplasmic protein
ChvE or cytoplasmic VirE1 or the VirE2 single-stranded
DNA-binding protein (SSB) in contrast to a previous finding
(6). Thus, we conclude that under the growth and induction
conditions of our experiments, VirB2, VirB5, and VirB7 are
the only VirB or VirE proteins exocellularly localized or re-
leased at appreciable levels into the extracellular milieu.
To purify the T pili, the sheared material was fractionated by
gel filtration chromatography and then by sucrose density gra-
dient centrifugation. In a representative experiment shown in
Fig. 2A and B, fractions 21 to 27 eluting from the gel filtration
columns contained abundant amounts of VirB2 and fractions
19, 29, and 31 contained lower but detectable levels (Fig. 2A).
Of considerable interest, both VirB5 and VirB7 exhibited very
similar elution profiles, with the most abundant levels of these
proteins being present in fractions 21 to 27 (Fig. 2A). The
molecular mass of the complex(es) composed of VirB2, VirB5,
FIG. 1. Identification of VirB2, VirB5, and VirB7 in the exocellular
fraction obtained by shearing of A348 cells. Blots were developed with
antisera to the VirB proteins listed, and an arrowhead marks the
position of the corresponding VirB protein. Abbreviations: E, exocel-
lular fraction containing surface organelles and proteins; C, cell pellet
recovered after removal of surface material by shearing as described in
the text; M, molecular mass markers, with sizes in kilodaltons indicated
at the left.
FIG. 2. Purification of T pilus through sucessive steps of gel filtration chromatography and sucrose density gradient centrifugation. (A) Gel
filtration fractions containing the VirB2, VirB5, and VirB7 proteins; the bottom blot is skewed slightly to the right relative to the top blot. (B)
Sucrose density gradient fractions containing VirB2, VirB5, and VirB7. Top blots in each panel were developed with anti-VirB2 antiserum, and
bottom blots were developed with anti-VirB5 and anti-VirB7 antisera. Positions of VirB proteins and sizes (in kilodaltons) of molecular mass
markers (M) are denoted. Lane GF, gel filtration fraction 21 loaded onto the sucrose gradient.
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and VirB7 exceeded 440 kDa, as judged by elution of the
440-kDa ferritin size marker in fractions 31 to 35.
Gel filtration fraction 21, which contained the most abun-
dant amounts of VirB2, VirB5, and VirB7, was centrifuged
through a 20 to 70% linear sucrose density gradient. As shown
in Fig. 2B, these VirB proteins copartitioned in the sucrose
gradients, providing further evidence for coassociation of these
proteins in a high-molecular-weight structure. We further
found that high-salt (1 M NaCl) treatment of gel filtration
fractions containing VirB2, VirB5, and VirB7 did not eliminate
comigration of these proteins in sucrose gradients, suggesting
that formation of this putative VirB complex is mediated by
hydrophobic rather than electrostatic interactions (data not
shown). Of interest, VirB2 was present at appreciably greater
levels in sucrose gradient fractions 6 and 7 than in adjacent
fractions, whereas VirB5 and VirB7 were distributed at com-
parable levels across several fractions. This difference in frac-
tionation behavior might be due to the presence of two sub-
populations of T pilus in the pilus preparations, one devoid of
and a second associated with a basal structure that we propose
is composed of VirB5 and VirB7.
Next, we examined the content of the sucrose fractions con-
taining the VirB proteins by transmission electron microscopy.
Sucrose was removed by dialysis and pili were concentrated by
centrifugation (see Materials and Methods). We detected T
pili similar in appearance to those visualized previously (Fig. 3)
(21). Typically, we saw long, flexible pili with an estimated
diameter of ;10 nm, as well as bundles of several T pili.
Occasionally, we also saw structures at one end of the pilus
resembling the terminal sacculi observed previously (29).
To further assay for VirB protein complexes, material from
the relevant gel filtration fractions was subjected to immuno-
precipitation analysis with anti-VirB antiserum. As repre-
sented by experiments shown in Fig. 4 in which gel filtration
fraction 21 (Fig. 2A) was used as starting material, protein
A-Sepharose and preimmune serum failed to precipitate these
VirB proteins. However, both the anti-VirB2 antiserum and
anti-VirB7 antiserum precipitated substantial amounts of
VirB2 and comparatively less VirB7. This uneven ratio of
VirB2 and VirB7 in the precipitated complexes and in the
sucrose fractions might be due to the association of VirB7 in
minor amounts at one position of the T pilus, possibly at the
pilus base.
Exocellular location of VirB7 in mutants defective in T-pilus
production. The above findings strongly suggest that VirB7
associates with the T pilus, as was shown previously for VirB5
(29). To determine whether the exocellular locations of VirB7
and VirB5 are dependent on T-pilus production, we assayed
for the presence of these proteins in fractions obtained from
each of the nonpolar DvirB mutants constructed in this labo-
ratory (4). Previous work determined that the DvirB1 mutant,
PC1001, as well as other nonpolar virB mutants, possesses no
extracellular pilin (21, 29). We detected a very low level of
VirB2 pilin in the exocellular fraction from the DvirB1 mutant
and none in fractions from any of the other DvirB mutants (Fig.
5). We detected low levels of VirB5 in the exocellular fraction
from wild-type A348 and none in fractions from the 11 DvirB
mutants (Fig. 5).
By contrast, VirB7 was present in the exocellular fractions of
all mutants except for those from which virB6 or virB7 was
deleted (Fig. 5). Results of studies describing the contribution
of VirB6 to VirB7 dimer formation are reported elsewhere
(17; S. Jakubowski, Z. Liu, and P. J. Christie, submitted for
publication). Exocellular VirB7 migrated predominantly as a
disulfide-cross-linked homodimer when samples were electro-
phoresed through gels under nonreducing conditions (Fig. 5).
We show elsewhere that the cellular form of VirB7 accumu-
lates at wild-type levels in all virB mutants except for DvirB6
and DvirB7 (Jakubowski et al., submitted); thus, the VirB7
homodimer apparently sorts to the outer face of the outer
membrane independently of T-pilus production and also inde-
pendently of most of the VirB proteins. However, it is also
evident that exocellular VirB7 is present in reduced levels in all
virB mutants compared to wild-type A348 (Fig. 5). This finding
suggests that the VirB proteins are important for accumulation
of wild-type levels of exocellular VirB7. Precisely how VirB7
interacts with the T pilus is unknown. Our inability to detect
integral membrane VirB proteins—including VirB4, VirB6,
VirB8, VirB10, and VirB11 (inner membrane), VirB9 (outer
membrane), and ChvE (periplasm)—in exocellular fractions
appears to exclude the possibility that VirB7 is associated with
membrane vesicles. Interestingly, however, we determined that
FIG. 3. Transmission electron microscopy showing purified T pili obtained from sucrose density gradients. The first two images were from
fraction 6 and second two were from fraction 8 of the sucrose gradient shown in Fig. 2. Arrowheads denote morphological features of interest,
including single T pili (diameter, ;10 nm), clumps of T pili, and occasional terminal sacculi as observed previously (20, 27). Pili were examined
at a magnification of 40,000. Bar, 100 nm.
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exocellular VirB7 from a DvirB2 mutant partitioned in sucrose
gradients as a high-molecular-weight species. Although this
species does not comigrate with VirB7 from T-pilus-producing
cells, these findings raise the possibility that exocellular VirB7
is released from the surface of pilus-deficient cells in associa-
tion with specialized vesicles (data not shown). Current studies
in this laboratory are characterizing the composition and pos-
sible function(s) of the exocellular VirB7 complexes isolated
from pilus-deficient cells.
VirB7 and VirB2 homodimers associate with T pilus. Cel-
lular VirB7 accumulates as a monomer, homodimer, and
VirB7-VirB9 heterodimer (Fig. 6, top right panel) (30). The
exocellular form of VirB7 that copurifies with the T pilus is
predominantly homodimeric (Fig. 6, bottom right panel).
Some monomeric VirB7 was evident, but the 36-kDa VirB7-
VirB9 heterodimer was not detected in pilus samples electro-
phoresed under nonreducing conditions (Fig. 6, bottom right
panel).
FIG. 4. Coprecipitation of a VirB2 and VirB7 complex presumptively corresponding to the T pilus with anti-VirB2 and anti-VirB5 antiserum
from gel filtration fraction 21 (GF21) (see Fig. 2). Blots showing VirB2 and VirB7 proteins in complexes precipitated with anti-VirB2 antiserum
(A) and with anti-VirB7 antiserum (B) are shown. Positions of VirB proteins and sizes (in kilodaltons) of molecular mass markers (M) are denoted.
Abbreviations: S, supernatant fraction following precipitation; P, pellet recovered upon precipitation with the reagents listed at the top of each
panel.
FIG. 5. Presence of the VirB7 homodimer in the exocellular fractions from the nonpolar DvirB mutants of A348 (4). Exocellular fractions were
from wild-type strain A348 (lane WT) and PC1001 (DvirB1) through PC1011 (DvirB11) (lanes 1 through 11, respectively). Blots were developed
with antisera to the VirB proteins denoted at the right. Samples analyzed with anti-VirB2 and anti-VirB5 antisera were electrophoresed under
reducing conditions; samples analyzed with anti-VirB7 antisera were electrophoresed under nonreducing conditions to show the relative abun-
dances of the VirB7 homodimer and monomer.
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Of further interest, although the cellular form of VirB2 is
monomeric, T-pilus-associated VirB2 migrated both as an ap-
parent homodimer and as a monomer (Fig. 6, left panels). The
pilus preparations contained similar levels of these two forms
of pilin. The material examined in Fig. 6 was derived from gel
filtration fraction 21, which corresponded to the earliest-elut-
ing, and presumably the largest, forms of T pilus (Fig. 2A).
When we assayed for pilin dimer formation in the total exo-
cellular fraction derived from T-pilus-producing cells or from
the gel filtration fractions containing smaller, presumably more
extensively broken forms of T pilus, we found that a smaller
fraction, estimated at less than 20% of pilin, migrated as an
apparent homodimer (Fig. 7). We propose that these and
other experimental findings presented below might be due to
disulfide cross-linking between a subset of pilin monomers that
are located at a discrete position along the T pilus.
The blots shown in the lower panels of Fig. 6 were generated
by electrophoresing the pilus-containing samples through the
same gel to clearly show the distinct migration of the VirB2
and VirB7 homodimers with predicted sizes of ;14 and 9 kDa,
FIG. 6. Association of VirB2 and VirB7 homodimers with the T pilus. Top panels, VirB2 and VirB7 species present in extracts from A348 cells
obtained after shearing to remove surface proteins and organelles. Extracts were electrophoresed under reducing (1bME) and nonreducing
(2bME) conditions. The cellular form of VirB2 pilin migrates as a monomer, whereas the cellular form of VirB7 migrates predominantly as a
disulfide-cross-linked dimer. A cross-reactive species of unknown composition is detected at a position corresponding to ;18 kDa. Bottom panels,
VirB2 and VirB7 species associated with T pili enriched from the exocellular fraction of A348 cells. The T-pilus-associated forms of both VirB2
and VirB7 migrated in nonreducing gels at positions corresponding to monomeric and disulfide-cross-linked homodimeric species. Positions of
VirB2 and VirB7 species and sizes (in kilodaltons) of molecular mass markers are denoted.
FIG. 7. Effects of Cys-to-Ser substitution mutations on accumulation of exocellular VirB2 and VirB7. Exocellular fractions were from A348
(WT), strains PC1002 carrying pBB8 (B2) or pVS10 (B2C64S), and strains PC1007 carrying pPC974 (B7), pXZ14 (B7C24S), or pXZ16 (B7C15S).
Top panels, protein samples were electrophoresed under reducing conditions. Bottom panels, protein samples were electrophoresed under
nonreducing conditions. Blots on the left were developed with anti-VirB2 antiserum, and blots on the right were developed with anti-VirB7
antiserum. Sizes (in kilodaltons) of molecular mass markers (M) are denoted in the center.
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respectively. In several repetititions of these experiments we
have been unable to detect a cross-reactive species migrating at
;11 kDa, the expected size of a VirB2-VirB7 heterodimer.
Role of VirB2 and VirB7 disulfide cross-linking and VirB7
lipid modification for T-pilus assembly. The mature form of
VirB2 possesses one internal Cys residue at position 64. To
determine if Cys64 is essential for T-pilus production, we ex-
amined the effect of a Cys64Ser substitution mutation. As
shown in Fig. 7, PC1002 cells expressing the alleles for native
VirB2 and for VirB2C64S accumulated both proteins at abun-
dant levels in the exocellular fraction. In contrast to native
VirB2, the VirB2C64S mutant protein failed to migrate as an
apparent homodimer when electrophoresed under nonreduc-
ing conditions (Fig. 7). Thus, disulfide cross-linking of VirB2
homodimers appears not to be essential for T-pilus production.
Mature VirB7 has two Cys residues, N-terminal Cys15 that
undergoes lipid modification and internal Cys24 that reacts to
form the disulfide-cross-linked dimers (13, 14). VirB7C15S is
unstable and nonfunctional, as shown by a failure of the cor-
responding allele to complement a DvirB7 mutation (14). To
examine the importance of VirB7 lipid modification for T-pilus
assembly, we assayed for the presence of T pili in exocellular
fractions of strain PC1007(pXZ16) expressing virB7C15S. As
shown in Fig. 7, PC1007(pXZ16) cells accumulated undetect-
able levels of exocellular VirB7C15S and VirB2 pilin, demon-
strating the importance of VirB7 lipid modification for pilus
formation. Our previous studies showed that Cys24 is impor-
tant for stability and functionality of VirB7 (31), although
another study reported that cooverexpression of virB7C24S,
virB8, and virB9 permitted successful T-DNA transfer (9). To
examine the importance of VirB7 disulfide cross-linking for
T-pilus production, we assayed for pilus production by strain
PC1007(pXZB14) expressing virB7C24S. As shown in Fig. 7,
avirulent PC1007(pXZB14) cells accumulated very low levels
of exocellular forms of VirB2 and VirB7C24S proteins. Thus,
VirB7 disulfide cross-linking contributes to efficient T-pilus
production.
We next examined whether disulfide-mediated dimerization
of VirB2 affects T-pilus function. Virulence assays were carried
out with isogenic PC1002 mutants expressing alleles for either
native VirB2 or VirB2C64S. Interestingly, whereas strain
PC1002(pBB8) exhibits wild-type virulence (4), the isogenic
strain PC1002(pVS10) synthesizing the substitution mutant
exhibited an attenuated virulence phenotype. Tumor induc-
tion was delayed by approximately 1 week, and tumors were
appreciably smaller than were tumors incited by strain
PC1002(pBB8) (Fig. 8). The extent of the attenuated function
of the C64S mutant pilin was assessed by inoculation of wound
FIG. 8. Effects of a Cys64Ser substitution mutation and DTT treatment of wild-type pilin on T-pilus assembly. (A) Virulence assays of PC1002
cells (D2) expressing wild-type VirB2 or VirB2C64S by inoculation of equivalent numbers of cells onto wounded Kalanchoe leaves. Cells
synthesizing the C64S mutant incited tumors of variable sizes that were reproducibly smaller than those incited by cells synthesizing wild-type pilin.
(B) T pilus composed of wild-type pilin enriched by gel filtration fraction chromatography was treated with 5 mM DTT, and both untreated and
DTT-treated T-pilus samples were fractionated through identically prepared sucrose density gradients. (C) T pilus composed of wild-type or C64S
mutant pilin present in the concentrated exocellular fractions from PC1002(pBB8) or PC1002(pVS10) cells, respectively, was fractionated through
sucrose density gradients.
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sites with serial dilutions of PC1002(pBB8) and PC1002
(pVS10) cultures. Results of these assays indicated that the
VirB2Cys64S substitution mutant was approximately 10- to
100-fold less virulent than the isogenic wild-type strain (data
not shown).
To assess the effect of the C64S mutation on T-pilus integ-
rity, we centrifuged the concentrated, exocellular fractions ob-
tained from PC1002(pBB8) and PC1002(pVS10) through su-
crose gradients and examined fractions for T-pilus distribution.
Care was taken to ensure that the gradients were identically
prepared and fractionated. As shown in Fig. 8, the pili com-
posed of wild-type and mutant pilin distributed differently in
the gradients. Whereas T pili assembled from wild-type pilin
were most abundant in sucrose fractions 6 to 8, the T pili
assembled from the C64S mutant partitioned predominantly in
fractions having a lower sucrose density. To further assess the
importance of intermolecular disulfide cross-linking for T-pilus
stability, we incubated a gel filtration fraction enriched for T
pilus composed of wild-type pilin in the presence of 5 mM
dithiothreitol (DTT) for 1 h at 30°C. Initial studies showed that
DTT-treated pilin migrates exclusively as a monomer in non-
reducing gels (data not shown). DTT-treated and untreated
pili were again size-fractionated by centrifugation through
identically prepared sucrose gradients. Interestingly, the DTT-
treated wild-type T pili also fractionated at a position of lower
sucrose density than did untreated T pili (Fig. 8). In the above-
mentioned gradients, both VirB5 and VirB7 exhibited shifts in
distribution similar to those of VirB2 pilin (data not shown).
Thus, both a C64S mutation and reduction of the C64S disul-
fide cross-link of wild-type pilin had the same phenotypic ef-
fect, namely, a sucrose fractionation profile suggestive of the
presence of shorter or less stable T pili than wild-type T pili not
exposed to a reductant. It is noteworthy that neither the C64S
mutation nor DTT treatment caused complete dissociation of
the T pilus. On the basis of these findings, we suggest that
VirB2 disulfide cross-linking, while not essential for T-pilus
production, nevertheless does contribute to pilus integrity and
function possibly by stabilizing subunit contacts at a specific
position(s) along the pilus.
DISCUSSION
The assembly of pili associated with type IV secretion sys-
tems is a poorly understood process. Recent studies have es-
tablished that T-pilus production at the A. tumefaciens cell
surface requires all of the VirB proteins, including VirB1, a
putative transglycosylase that is dispensable for T-DNA trans-
fer (4, 21). These findings led to the proposal that the pre-
sumed virB-encoded mating apparatus provides the channel
for translocation of VirB2 pilin from its inner membrane res-
ervoir to its site of polymerization (20). If this scenario is
correct, VirB2 pilin can be considered a bona fide substrate of
the translocation channel, adding to the list of secretion sub-
strates such as VirE2 SSB, VirF, and the T-strand-VirD2 and
the RSF1010-MobA transfer intermediates. It is of interest,
however, that the VirD4 putative ATPase is dispensable for
T-pilus production but is required for intercellular substrate
trafficking (21). VirD4 is a member of a family of coupling
proteins that are proposed to function as docking sites for
secretion substrates at the base of the transfer machine (16).
Therefore, if VirB2 pilin is indeed translocated through the
mating channel, it must enter this secretory machine via a
different pathway from that used by the secretion substrates
destined for intercellular transfer.
It is alternatively possible that the T-pilus biogenesis path-
way does not depend on prior assembly of the translocation
channel. According to this model, some of the VirB proteins
might participate in the dynamics of pilus biogenesis, while the
remaining VirB proteins provide a structure for anchoring the
pilus to the cell envelope. Candidates that might actively pro-
mote the delivery of VirB2 pilin to its site of assembly include
the VirB11 ATPase, whose multimerization as a double-ring,
chaperone-like structure is inferred from genetic and biochem-
ical findings (28) and a recent crystal structure of the H. pylori
HP0525 homolog (35). In addition, VirB5 has been postulated
to function as a periplasmic chaperone that delivers pilin from
its inner membrane reservoir to the outer membrane by a
route independent of the virB-encoded mating channel (23).
Most of the remaining VirB proteins—i.e., VirB4, VirB6,
VirB7, VirB8, VirB9, and VirB10—might assemble as a trans-
envelope structure that could alternatively (or dually) serve as
a platform for pilus assembly or the mating channel for inter-
cellular translocation of the VirE2, VirF, and DNA transfer
intermediates.
To begin dissecting the functions of VirB proteins in the
pilus assembly pathway, a reasonable starting point is the elu-
cidation of the roles of the three VirB proteins, VirB3, VirB7,
and VirB9, that localize at the outer membrane (13, 19;
Jakubowski et al., submitted). These outer membrane proteins
are the best candidates for assembling as a structure required
for pilus production. Previous work determined that VirB7 is
processed as a lipoprotein and that it assembles as a disulfide-
cross-linked homodimer and a VirB7-VirB9 heterodimer (1,
13, 14, 30). On the basis of observed stabilizing activities, we
postulated that the VirB7-VirB9 heterodimer functions as a
nucleation center for recruitment of VirB proteins during as-
sembly of the T-DNA transfer machine (14). However, our
early studies did not provide any clues about the function of
the VirB7 homodimer. Despite the capacity of a virB9 deletion
mutant to assemble VirB7 homodimers, this mutant still accu-
mulated low levels of several VirB proteins, suggesting that the
homodimer is not a general stabilizing factor for the VirB
proteins (4). We also assayed for isomerization of the ho-
modimer disulfide cross-link with a strain expressing virB7
from the Plac promoter and virB9 from the PvirB promoter. In
this experiment, cells were pretreated with IPTG to induce
virB7 expression and assembly of the VirB7 homodimer,
washed to remove IPTG, and incubated with AS to induce
expression of virB9. Despite the accumulation of preassembled
VirB7 homodimer, these cells did not accumulate detectable
levels of the VirB7-VirB9 heterodimer, suggesting that the
homodimer is not simply an intermediate in the VirB7-VirB9
assembly pathway (X. R. Zhou and P. J. Christie, unpublished
data).
In the present study, we showed that the VirB7 homodimer
localizes exocellularly independently of most of the other VirB
proteins. Several lines of evidence suggest that VirB7 assem-
bles at a discrete site(s) on the cell surface as a complex or
structure that is relevant to pilus biogenesis. First, we have
found that the VirB7 homodimer cofractionates with two pilus-
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associated proteins, VirB5 (29) and the VirB2 structural sub-
unit (22), through successive steps of gel filtration and sucrose
density gradient fractionation used for purification of the T
pilus. VirB2, VirB5, and VirB7, but no other VirB proteins,
were detected in exocellular fractions or purified T-pilus prep-
arations from A348 cells. Second, the exocellular VirB7 ho-
modimer tightly associates with the T pilus. This was shown by
its cofractionation with a high-molecular-weight, VirB2-con-
taining structure in the presence of high salt and by the dem-
onstration that VirB7 and VirB2 coprecipitate from exocellu-
lar fractions. Third, exocellular VirB7 produced by a DvirB2
mutant and by wild-type cells displayed different distribution
patterns in sucrose gradients. These last two findings appear to
exclude the possibility that VirB7 complexes coincidentally
cofractionate with VirB2 during the T-pilus purification. In
addition, we note that the production of exocellular VirB7
homodimer requires VirB6, and the abundance of this species
is influenced by production of each of the VirB proteins (Fig.
5) (19). These findings further support the notion that exocel-
lular VirB7 lipoprotein forms a physiologically relevant com-
plex with the T pilus.
We propose that the site of interaction between the VirB7
lipoprotein and the T pilus is the outer membrane; at this
location, the covalently attached lipid groups most probably
embed into the outer leaflet anchoring VirB7 to the mem-
brane. It should be noted, however, that the lipid anchor is not
tenacious; previous work has shown that lipoproteins bound to
the membrane exclusively by fatty acylation are easily removed
from the membranes during cell fractionation (see reference
13). This property probably explains why the monomeric and
homodimeric forms of VirB7 were coextracted with the T pilus
during shearing of the cells and pilus purification. A loose
membrane association might also account for the presence of
exocellular VirB7 in the various virB gene deletion mutants.
We suspect that in these mutants VirB7 fails to establish sta-
bilizing contacts with the T-pilus–translocation channel; there-
fore, VirB7 might be easily extracted from the membranes
upon shearing. We acknowledge, however, that it might be
premature to conclude that VirB7 functions exclusively in pilus
biogenesis during the infection process. For example, previous
work has established that T pili (and other related conjugative
pili) are readily sloughed from the cell surface during growth
(21, 22). Any molecules released from the surfaces of bacterial
pathogens are potential signals for eukaryotic target cells; thus,
exocellular VirB7 lipoprotein either in association with
sloughed T pili or released to the milieu independently of the
T pilus could activate host cellular processes required for the
establishment of successful infection. Current studies in the
laboratory are examining the possibility that VirB7 lipoprotein
contributes to the A. tumefaciens infection process by a mech-
anism distinct from its role in T-pilus biogenesis at the bacte-
rial cell surface.
Both VirB7 lipoprotein and outer membrane protein VirB9
clearly are essential for pilus formation on the basis of their
demonstrated roles in stabilizing other VirB proteins and the
failure of DvirB7 and DvirB9 mutants to elaborate T pili (3, 14,
21). The VirB7-VirB9 heterodimer was not detected in T-pilus
preparations, but this likely is because VirB9 is an integral
outer membrane protein and therefore is refractory to removal
from the cell surface by shearing. On the basis of the available
data, we therefore propose that both VirB7 dimers assemble at
the outer membrane as a heteromultimeric complex or struc-
ture required for pilus assembly. The specific function of this
putative structure remains to be elucidated, but two possibili-
ties include the configuration as a platform corresponding to
the site of pilus assembly or as a channel that permits passage
of pilin subunits or the T pilus itself across the outer mem-
brane.
With respect to the latter possibility, oligomeric ring-like
complexes termed secretons are now known to be required for
assembly and function of many secretion and organellar bio-
genesis systems of gram-negative bacteria (32). Relevant to
pilus biogenesis, secretons mediate the delivery of structural
subunits to the pilus assembly site at the outer membrane, e.g.,
E. coli PapC (33), or they serve as channels for pilus outgrowth,
e.g., Pseudomonas aeruginosa PilQ (26). Relevant to VirB7-
VirB9, in several cases the secreton structural subunit interacts
with a cognate lipoprotein (31). Indeed, the outer membrane
lipoprotein WzaK30 was itself recently shown to assemble as
an oligomeric channel; this secreton promotes translocation of
group 1 capsular polysaccharide to the surface of E. coli (11).
An intriguing speculation that awaits further study is whether
one or both of the VirB7 dimers assemble as an oligomeric ring
at the outer membrane for T-pilus assembly and/or substrate
translocation.
Finally, our studies have contributed insights about the T-
pilus assembly pathway with respect to VirB2 processing re-
quirements. Others have shown that VirB2 is processed most
probably by signal peptidase I at a sequence that is conserved
among other members of this pilin family (22). VirB2 then
undergoes a novel cyclization reaction that results in a head-
to-tail peptide bond formation (12). Both the signal sequence
cleavage and cyclization reactions are thought to occur imme-
diately upon localization of the pilin at the inner membrane.
We have shown that this inner membrane reservoir of VirB2
does not form intermolecular cross-links. Conceivably, the pi-
lin is embedded into the membrane in such a way as to render
the unique Cys64 residue unavailable for disulfide cross-link-
ing. At some point, an unknown signal activates pilus polymer-
ization; this reaction involves a dynamic restructuring of pilin
monomers from their inner membrane location to a site of
pilus assembly. We suggest that it is during this recruitment
step that a subset of pilin monomers form intermolecular
cross-links. It is formally possible that these cross-links form
spontaneously, because the Cys64 residue marks a site of close
contact between two pilin monomers in the assembled T pilus.
However, two lines of evidence suggest that pilin cross-linking
is a physiologically relevant event. First, mutants synthesizing
VirB2C64S reproducibly displayed an attenuated virulence
phenotype compared to an isogenic strain synthesizing wild-
type pilin. Second, both T pili assembled from VirB2C64S and
DTT-treated, wild-type pili displayed fractionation patterns in
sucrose gradients suggestive of a reduction in pilus length
compared to untreated, wild-type T pili. On the basis of these
findings, we suggest that disulfide cross-linking might occur at
a discrete site along the pilus, possibly at its base, in order to
stabilize specific contacts or regions of the T pilus. These
cross-links are dispensable for pilus production but might be
important for pilus retention at the plant wound site.
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